The British pharmaceutical company said combinations for its Blenrep drug were evaluated in adults with relapsed or ...

The comeback story of belantamab mafodotin (Blenrep) hit a roadblock Thursday as the FDA's Oncologic Drugs Advisory Committee ...

The Senate Appropriations Committee has approved $27.1 billion in discretionary spending through the Fiscal Year 2026 Agriculture, Rural Development, Food and Drug Administration and Related Agencies ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

A group of independent advisors to the U.S. Food and Drug Administration (FDA) on Thursday voted against the approval of a combination drug regimen involving GSK’s (NYSE:GSK) blood cancer medicine ...

Decades of research show the mercury-containing preservative thimerosal is safe in vaccines, but CDC's new advisory panel is ...

His threats to his department, vaccine access, and accurate information could harm vulnerable groups, critics say.

FDA reviewers have identified high rates of ocular toxicity as GSK looks to place its blood cancer drug back on the market.

While the U.S. government still officially considers marijuana a Schedule I drug with no accepted medical use, federal agencies are increasingly breaking with that position. In one notable example, an ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

Warren police have persuaded the City Council to seek rules for selling a synthetic offshoot of kratom that mimics the euphoria of opioids.

The panel’s top Democrat Sen. Richard Blumenthal, D-Conn., shared Johnson’s concerns of big pharma and pledged to co-sponsor ...